Gallbladder cancer (GBC) is the most common cancer of the biliary tract, characterized by a
very poor prognosis when diagnosed at advanced stages owing to its aggressive behaviour …

Cancers are generally recognized as the leading cause of death and a predominant barrier
to prolonging life expectancy in both developed and developing countries. Emodin is a …

Despite conventional treatment modalities, gallbladder cancer (GBC) remains a highly lethal
malignancy. Prognostic biomarkers and effective adjuvant immunotherapy for GBC are not …

Gallbladder cancer is a rare malignancy of the biliary tract with a poor prognosis, frequently
presenting at an advanced stage. While rare in the United States overall, gallbladder cancer …

Background Abnormal angiogenesis is crucial for gallbladder cancer (GBC) tumor growth
and invasion, highlighting the importance of elucidating the mechanisms underlying this …

Abstract Uncoupling protein 2 (UCP2) is a mitochondrial anion carrier which plays a key role
in energy homeostasis. UCP2 is deregulated in several human cancers and has been …

Objective: Gallbladder cancer (GBC) mortality remains high and chemoresistance is
increasing. This review consolidates what is known about the mechanisms of …

Gallbladder cancer (GBC) is the most common malignancy of the bile duct and has a high
mortality rate. Here, we demonstrated that BRD 4 inhibitor JQ 1 and histone deacetylase …

Gallbladder cancer (GBC) is infrequent but most lethal biliary tract malignancy characterized
by an advanced stage diagnosis and poor survival rates attributed to absence of specific …

Gallbladder cancer is a rare malignancy in most countries. The racial and sociodemographic
factors associated with its incidence and survival are poorly defined. We aimed to …